N. Bhardwaj
Immunology · Journal of Experimental Medicine · 2000–2021
A researcher in the Science corpus: 12 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 221 citations into it; #952 of 2,160 by trust here, #402 by citations
Whom N. Bhardwaj trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- R. Steinman (in Immunology)
Who trusts N. Bhardwaj
- E. Shevach (in Immunology)
- Yong‐jun Liu (in Immunology)
- L. Walker (in Immunology)
- A. Abbas (in Immunology)
Papers from N. Bhardwaj's perspective
Ordered by how strongly the researchers N. Bhardwaj trusts endorse each paper. Same corpus, a different order for every researcher.
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
- Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells (Journal of Experimental Medicine)
- Immunogenic cell death in cancer therapy. (Annual Review of Immunology)
- The future of immune checkpoint therapy (Science)
- PD-1 and its ligands in tolerance and immunity. (Annual Review of Immunology)
- Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells (Nature Medicine)
- A Discrete Subpopulation of Dendritic Cells Transports Apoptotic Intestinal Epithelial Cells to T Cell Areas of Mesenteric Lymph Nodes (Journal of Experimental Medicine)
- The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. (Annual Review of Immunology)
- The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. (Immunity)
- Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny (Nature reviews. Immunology)
Their papers
- Therapeutic cancer vaccines (2021) — 1,125 citations
- A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer. (2020) — 621 citations
- Immunology of COVID-19: Current State of the Science (2020) — 1,500 citations
- A conserved dendritic-cell regulatory program limits antitumour immunity (2020) — 749 citations
- A Natural Killer/Dendritic Cell Axis Defines Responsive Tumor Microenvironments in Melanoma (2018) — 856 citations
- Dendritic cell-based immunotherapy (2016) — 653 citations
- Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma (2016) — 890 citations
- Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition (2016) — 1,074 citations
- Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. (2005) — 716 citations
- Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. (2001) — 908 citations
- Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells (2001) — 1,511 citations
- Consequences of Cell Death (2000) — 1,513 citations